The Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) of Université de Montréal will attend the 2016 BIO International Convention. This conference is being held from June 06 to June 09, 2016 at the Moscone Center in San Francisco, California.
For more information about 2016 BIO International Convention click here : BIO International Convention
For a meeting with the IRICoR representatives during the conference, please contact Steven Klein ( firstname.lastname@example.org) or Nadine Beauger (email@example.com).
About the Institute for Research in Immunology and Cancer – Commercialization of Research
IRICoR is a not-for-profit organization whose mandate is to accelerate the discovery, development and commercialization of novel drugs that originate from Université de Montreal’s Institute for Research in Immunology and Cancer, related research units and collaborating centres. IRICoR invests in highly innovative projects to rapidly transition them from academia to the market, while identifying the best development partners for these commercially promising projects. For more information: www.iricor.ca
Steven Klein Ph.D., MBA
Vice-President, Business Development
T +1 514 343.6647